Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

Clinical trial NCT06023758 · RECRUITING

Trial details

NCT number: NCT06023758
Sponsor: Peking University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Locally Advanced Resectable Gastric Cancer

Start date: 2023-09-22
Primary completion: 2025-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.